학술논문
Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283
Document Type
Article
Author
Source
In Cancer Letters 1 November 2014 354(1):68-76
Subject
Language
ISSN
0304-3835